Lantern Pharma is trading 5.6% up at $3.27 in a technical rebound following two sessions of sharp declines.
- The stock is recovering from yesterday’s 13.17% drop to $3.10, with no fresh company-specific news or analyst actions reported today.
- The move appears to be driven by a technical bounce amid broadly positive market sentiment, as major indices are trading up approximately 0.6–0.8%.